Osteoarthritis Trial, Recruiting NCT06148779 Sponsor: Joint Academy Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06148779
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already registered in the Joint Academy database and have previously taken part in the Joint Academy treatment program for osteoarthritis (a joint condition causing pain and stiffness), and who agreed to have their data used for research.
  • People who have been diagnosed with hip or knee osteoarthritis by a doctor or physiotherapist, either through imaging (such as an X-ray) or through a clinical assessment.
  • People without a prior diagnosis who had osteoarthritis confirmed by an orthopaedic specialist or physiotherapist over the phone, following recognised clinical guidelines, and with no serious warning signs of another condition.
  • People who joined the program from October 1st 2021 onward must have had a physical examination by a doctor or physiotherapist before starting the treatment program.

Who may not be able to join:

  • People who have not participated in the Joint Academy treatment program for osteoarthritis.
  • People who did not give consent for their data to be used in research.
  • People who showed signs of a serious underlying condition (referred to as "red flag symptoms") at the time of assessment, unless they were first seen in person by a healthcare provider and cleared for inclusion (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Leif E Dahlberg, Senior professor, Joint Academy

Phone: +46406550292

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Joint Academy
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
30 June 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Postal code/Official Municipality Key; Postal code/Official Municipality Key for primary care center

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov